Cernostics

company

About

Cernostics is a life science company developing new molecular diagnostic tests to treat cancer.

  • Danville,Pennsylvania,United States
  • 11 - 50

Details

Last Funding Type
Debt Financing
Industries
Biotechnology,Health Diagnostics,Life Science,Medical Device
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Cernostics, Inc
Also Known As
Cernostics Pathology Inc.

Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells.

Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
12
$21.26M
Cernostics has raised a total of $21.26M in funding over 2 rounds. Their latest funding was raised on Aug 13, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 13, 2021 Series Unknown $5.98M Detail
Mar 21, 2018 Series A $2.50M 1 Illumina Ventures Detail
Aug 31, 2016 Series Unknown $5M 2 UPMC Detail
Jun 8, 2015 Series Unknown $1.96M 1 Ben Franklin Technology Partners of Northeastern Pennsylvania Detail
Feb 20, 2014 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
4
7
Cernostics is funded by 7 investors. Illumina Ventures and UPMC are the most recent investors.
Investor Name Lead Investor Funding Round
Illumina Ventures Yes Series A
UPMC Yes Series Unknown
Ben Franklin Technology Partners of Northeastern Pennsylvania Yes Series Unknown
Novitas Capital Series Unknown
Geisinger Series B
Pittsburgh Life Sciences Greenhouse Series B
Geisinger Ventures Series A

Employee Profiles

Number of Employee Profiles
4
Cernostics has 4 current employee profiles, including Advisor Paul L. Kornblith